探索国家和区域政策干预措施的证据基础
Osman A Dar1, Rumina Hasan2, Jørgen Schlundt3
1Public Health England, London, UK; Chatham House Centre on Global Health Security, London, UK.
Lancet (London, England)
|November 26, 2015
概括
有效的抗生素耐药性政策需要更多证据. 一个健康的方法和全面的评估对于在不同的全球环境和部门中制定适应性战略至关重要.
科学领域:
- 公共卫生
- 流行病学
- 卫生政策
背景情况:
- 抗菌素耐药性 (AMR) 构成了全球严重的健康威胁.
- 目前对抗药物耐药性控制的政策缺乏充分理解的有效实施证据基础.
- 干预措施必须考虑不同的国家收入水平,并整合人类,动物和环境健康部门.
研究的目的:
- 评估现有的抗菌素耐药性控制政策的有效性.
- 确定国家和区域影响的关键政策领域:负责任的使用,监测和感染预防和控制.
- 为加强各种环境的政策干预提供建议.
主要方法:
- 政策领域的分析:负责任的使用,监测,感染预防和控制.
- 考虑跨部门和监管环境的实施复杂性.
- 倡导使用标准化框架进行全面的政策评估,以确保成本效益和通用性.
主要成果:
- 现有政策对抗抗菌素耐药性的有效性尚未得到充分了解.
- 在不同部门和政治/监管环境中存在实施挑战.
- 需要更多的证据来指导政策干预.
结论:
- 建议对成本效益和通用性进行全面的政策评估.
- 这些评估对低收入和中等收入国家以及动物/环境部门尤为重要.
- 建议采用"一个健康"的方法,制定敏感的,针对特定部门和区域的抗菌素耐药性控制政策.
更多相关视频
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
8.4K
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.6K
相关概念视频
Clinical Significance of Antibiotic Resistance
32
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
32
Development of Antibiotic Resistance
1.9K
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.9K
Mechanism of Antibiotic Resistance in MRSA
99
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
99
Antimicrobial Effectiveness
2.0K
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
2.0K
Antibiotic Selection
62.1K
Overview
62.1K
Combined Effects of Drugs: Synergism
7.4K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
7.4K
